Awards & Advancement

Zyngenia appoints Frank Hsu as chief medical officer

Thursday, May 31, 2012 02:10 PM

Zyngenia, a Gaithersburg, Md.-based biopharmaceutical company developing next-generation multi-specific antibody-based drugs, has appointed Frank Hsu, M.D., as chief medical officer and a member of its executive team.

More... »

Akesis names John L. Capicchioni as new president

Thursday, May 31, 2012 12:34 PM

Akesis, a Lake Wylie, S.C.-based contract research firm specializing in phase II-IV clinical dermatology services and regulatory affairs consulting, has appointed John L. Capicchioni as its new president.

More... »

Joshua Boger joins Alkeus Pharmaceuticals as executive chairman

Friday, May 25, 2012 01:21 PM

Alkeus Pharmaceuticals of Boston, Mass., has appointed Joshua Boger, Ph.D., as executive chairman of the company's board of directors. 

More... »

Paratek appoints Molnar and Loh to senior positions

Thursday, May 24, 2012 09:00 AM

Paratek Pharmaceuticals of Boston, Mass., has named Dennis Molnar as director, president and CEO, and Evan Loh, MD, as chief medical officer and chairman of the board of directors.  

More... »

AMRI names new president for AMRI Europe

Wednesday, May 23, 2012 12:05 PM

AMRI, a global contract research and manufacturing organization, has appointed Ian Shott as president of AMRI Europe.

More... »

Datatrak selected as 2012 Crain's Leading EDGE honoree

Monday, May 21, 2012 12:08 PM

Datatrak International, a technology and services company focused on global eClinical solutions for the clinical trials industry, has been selected as a 2012 Crain's Leading EDGE award winner for the third consecutive year.

More... »

Icon makes senior appointments

Monday, May 21, 2012 11:52 AM

Icon, a global provider of outsourced development services, has appointed Dr. Susan Anton as director of epidemiology and risk management practice, Icon late phase & outcomes research, and Dr. Pui Leung as senior clinical research physician, Icon Development Solutions.

More... »

Synthetic Biologics appoints Carol Reed as senior vice president

Thursday, May 17, 2012 11:12 AM

Synthetic Biologics, an Ann Arbor, Mich.-based developer of synthetic DNA-based therapeutics and disease-modifying medicines for serious illnesses, has appointed Carol Reed, M.D., as senior vice president of clinical & regulatory affairs.

More... »

Insmed appoints Hayden, Jr. as executive chairman

Thursday, May 17, 2012 10:45 AM

Insmed, a Monmouth Junction, N.J.-based biopharmaceutical company focused on inhalants, has appointed Donald J. Hayden, Jr. as executive chairman of the company's board of directors.

More... »

Medivir appoints Juserius commercial executive vice president

Thursday, May 17, 2012 10:44 AM

Medivir, a Stockholm-based specialty pharmaceutical company focused on infectious diseases, has appointed Henric Juserius to head the company's commercial activities.

More... »